RefleXion Medical Stock
Biologically-Guided Radiotherapy Systems for Patients with Cancer
Sign up today and learn more about RefleXion Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About RefleXion Medical Stock
RefleXion Medical is a privately held medical device company developing the first biology-guided radiation therapy system for cancer treatment. By leveraging Positron Emission Tomography (PET) in a novel way, RefleXion's patented technology will allow tumors to continuously signal their location during treatment and potentially revolutionize the practice of radiation oncology. Early validation of RefleXion's technology was funded by the National Cancer Institute. RefleXion is backed by premier investors; Sofinnova Partners, KCK, Pfizer, Venrock and Johnson & Johnson Innovation.
Chief Executive Officer
Chief Financial Officer
Chief Technology Officer